2m 2m 2m 2m 2m 2m 2m
AIM IMMUNOTECH (AIM)
NYSE
$0.15+$0.003 (+1.75%)
Price as of Nov 12, 2026 8:12 AM EST- $5.9MMarket Cap
- -90.60%1-Year Change
- BiotechnologyIndustry
AIM IMMUNOTECH (AIM)
$0.15+$0.003 (+1.75%)
AIM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.15 | ||
Change | +$0.01 (+7.54%) | ||
Open | $0.15 | ||
High | $0.15 | ||
Low | $0.14 | ||
Previous Close | $0.14 | ||
Volume | 684,945 | ||
30-Day Average Volume | 549,410 | ||
1-Week Change | -7.83% | ||
1-Month Change | -17.56% | ||
1-Year Change | -90.60% | ||
3-Year Change | -64.88% | ||
5-Year Change | -91.26% | ||
Fundamentals | |||
Shares Outstanding | 39.9M | ||
Total Assets | $12.7M | ||
Market Cap | $5.9M | ||
Enterprise Value | -$358,606.00 | ||
Period: QTR TTM FY | |||
Revenue | $26,000.00 | ||
Net Income | N/A | ||
Free Cash Flow | -$4.6M | ||
EBIT | $0.00 | ||
EBITDA | $537,000.00 | ||
Net Working Capital | $5.5M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | -14 | ||
P/B | 1 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1001 : 1000 | ||
Last Split Date | 01/09/2026 | ||
Earnings & Revenue